Effect of Antiepileptic drugs on lipid profile in children with Epilepsy
Abstract
Objective: The study evaluated the effect of antiepileptic drugs on lipid profile in children with epilepsy. Demographic profile and the seizure pattern of CWE were also studied.
Material and method: 95 children aged between 2-15 years with confirmed diagnosis of primary epilepsy who were on AED for at least 3 months were the cases and 50 normal healthy children of similar age group were the controls. Children with BMI >95th entile were excluded. The cases were categorized in three groups depending upon whether they were taking either phenytoin, valproic acid alone or in combination.
Result: The Levene‘s test for homogeneity of variance indicated a significant difference in variance between the cases and control group in serum TGs, LDL-C and VLDL-C. The t-test showed a significant difference in means among cases and controls in HDL-C, LDL-C levels and the risk ratio.
Conclusion: We recommend a need for careful monitoring of lipid profile in children with epilepsy receiving antiepileptic drugs
Downloads
References
2. Beilmann A, Napa A, Soot A,Talvik I, Talvik T. Prevalence of childhood epilepsy in Estonia. Epilepsia .1990 ;40 : 1011-1019.
3. Sidenvail R, Forsgren L, HeijbelJ. Prevalence and characteristics of epilepsy in children in Northern Sweden.Siezure .1965;5:139-146. [PubMed]
4. Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India.Epilepsia.1999;40:631-636. [PubMed]
5. Nicoletti A1, Reggio A, Bartoloni A, Failla G, Sofia V, Bartalesi F, Roselli M, Gamboa H, Salazar E, Osinaga R, Paradisi F, Tempera G, Dumas M, Hall AJ. Prevalence of epilepsy in rural Bolivia. A door to door survey.Neurology.1990; 53:2064-2069. [PubMed]
6. Christianson AL, Zwane ME, Manga P, Rosen E, Venter A. Epilepsy in rural South Africa children-prevalence ,associated disability and management.S Afr Med J.2000;90:262-266.
7. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002;110: Epilepsia.53–57. [PubMed]
8. Miura H. Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies.2004;13,17-23.
9. Friedewald WT, Levy RI and Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge: Clinical Chemistry June 1972 vol. 18 no. 6 499-502.
10. Pooja Dewan, AnjuAggarwal and Faridi MMA. Effect of phenytoin and valproic acid therapy on serum lipid level an liver, Indian Pediatrics 2008;45:855-858. [PubMed]
11. Anju Aggarwal, Manish Kumar and Faridi MMA. Effect of Carbamazepine on Serum Lipids and Liver Function Tests brief reports 2005 September 17 volume 42:913-918. [PubMed]
12. Geda G, Çasken H and Icagasioglu D. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapyActa Article, 2002, Vol. 102/3. [PubMed]
13. Yalçin E, Hassanzadeh A, Mawlud K. The effects of long-term anticonvulsive treatment on serum lipid profile. Acta Paediatr Jpn.1997 Jun;39(3):342-5. [PubMed]
14. Verrotti A, Basciani F, Domizio S, Sabatino G, Morgese G, Chiarelli F Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Paediatric neurology Nov 1998 Volume 19, Issue 5, Pages 364-367. [PubMed]
15. Emilio Franzoni, Marina Govoni, Sergio D'Addato, Stefano Gualandi, Zina Sangiorgi, Gian Carlo Descovich, Gian Paolo Salvioli. Total cholesterol, high density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs. Epilepsia 1992 ; 33: 932-935.
16. Berlit P, Krause KH, Heuck CC, Shellenberg B. Serum lipids and anticonvulsants. Acta Neurol Scand 1982; 66: 328-334. [PubMed]
17. Pelkonen R, Fogelholm R, Nikkila EA. Increase in serum cholesterol during phenytoin treatment. BMJ 1975; 283: 85. [PubMed]
18. Pita-Calandre E, Rodríguez-López CM, Cano MD, Peña-Bernal M. Rev Neurol.1998 Nov;27(159):785-9. [PubMed]
19. Nikkilä EA, Kaste M, Ehnholm C, Viikari J. Epilepsy research, August 2000, vol 41,(1)1-7.
20. O’Neill B, Callaghan N, Stapleton M, Molloy W. Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin. Acta Neurol Scand 1982;65:104-109.
OAI - Open Archives Initiative
